SMAD4 and familial pancreatic carcinoma: SMURF1 is a known inhibitor of TGFβ signaling (by promoting degradation of its receptor TGFβRI, and signaling mediator SMAD4 [15], [16]), a pathway frequently disrupted in pancreatic cancer.